Skip to main content
University of Minnesota
Main navigationMain content
University of Minnesota
http://twin-cities.umn.edu/
612-625-5000
Go to the U of M home page
Home
CIDRAP

Main navigation

  • News
    • Antimicrobial Resistance
    • COVID-19
    • Chronic Wasting Disease
    • Influenza
    • Resilient Drug Supply
    • All Topics A-Z
    • Coronavirus Vaccines Roadmap
    • Influenza Vaccines Roadmap
    • Roadmaps for Priority Pathogens
    • Vaccine Integrity Project
    • CIDRAP Leadership Forum
    • .
    • .
    Topics & Projects
    • Antimicrobial Stewardship
    • Chronic Wasting Disease
    • Osterholm Update
    Podcasts
  • Newsletters
    • About CIDRAP
    • CIDRAP in the News
    • Our Staff
    • Our Director
    • Osterholm in the Press
    • Shop Merchandise
    • Contact Us
    About

  • Support
Menu

Ebola

RSS feed

Suspected Ebola outbreak in Congo has caused 50 deaths

(CIDRAP News) – The World Health Organization (WHO) reports that 50 people in the Congo have died of a suspected acute hemorrhagic fever syndrome. A Reuters report said the disease is suspected to be Ebola virus infection.

 
 

Bush initiative would promote new defenses against bioterror diseases

Editor's note: This story was updated Jan 30, 2003, with additional information from the Department of Health and Human Services.

(CIDRAP News) – President Bush yesterday proposed an initiative, called Project Bioshield, to speed the development and production of vaccines and treatments for smallpox, anthrax, botulism, and other diseases that could be spread by terrorists.

 
 

Healthcare system not ready for attack with hemorrhagic fever viruses

From May 8 JAMA
Robert Roos
 
 

NIAID releases lengthy bioterrorism research agenda

(CIDRAP News) – The National Institute of Allergy and Infectious Diseases (NIAID) has released a 68-page report on its plan for expanding research on "Category A" bioterrorism agents: anthrax, smallpox, plague, tularemia, viral hemorrhagic fevers, and botulism.

 
 

Pagination

  • « First First page
  • ‹ Previous Previous page
  • …
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135

Our underwriters

Unrestricted financial support provided by

Bentson Foundation logo
Principal Underwriter
Unorthodox Philanthropy logo
Leading Underwriter
3M Logo
Major Underwriter
Gilead Logo
Supporting Underwriter
Albert Victor Ravenholt Fund
Supporting Underwriter
Become an Underwriter
Bordetella pertussis - Maroon

Help make CIDRAP's vital work possible

Support Us
  • Home
  • Editorial policy
  • Search news
Visit us on Facebook
Twitter
Bluesky
Youtube
Linkedin
RSS

Contact Us

CIDRAP - Center for Infectious Disease Research & Policy
Research and Innovation Office, University of Minnesota, Minneapolis, MN

Email us

© 2025 Regents of the University of Minnesota. All rights Reserved.
The University of Minnesota is an equal opportunity educator and employer

Research and Innovation Office |   Contact U of M  |  Privacy Policy

Newsletter subscribe

Choose newsletters

Email Format
  • News
  • Topics & Projects
    • Antimicrobial Resistance
    • COVID-19
    • Chronic Wasting Disease
    • Influenza
    • Resilient Drug Supply
    • All Topics A-Z
    • Coronavirus Vaccines Roadmap
    • Influenza Vaccines Roadmap
    • Roadmaps for Priority Pathogens
    • Vaccine Integrity Project
    • CIDRAP Leadership Forum
    • .
    • .
  • Podcasts
    • Antimicrobial Stewardship
    • Chronic Wasting Disease
    • Osterholm Update
  • Newsletters
  • About
    • About CIDRAP
    • CIDRAP in the News
    • Our Staff
    • Our Director
    • Osterholm in the Press
    • Shop Merchandise
    • Contact Us
  • Donate